Evolent Health, Inc.
EVH- Exchange
- NYSE
- Industry
- Services-Management Services
- SEC CIK
- 0001628908
Insider trades, last 90 days
0 buys · 1 sell
- Sold $329.46K
- Open-market purchases (P) and sales (S), counted by Form 4 filing.
13F holders, Q2 2026
220
- +5 vs. Q1 2026
- Total value $1.02B
Superinvestors holding EVH
0
- None of the superinvestors held EVH at the end of Q2 2026.
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by EVH insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Aug 28, 20264:17 PM ET | Aug 26, 2026 | McCarthy Daniel JosephPRESIDENT | SSaleClass A Common Stock | −65.89K | $5.00 | −$329.46K | 655.13K | −9.1% | SEC10b5-1 |
| Nov 19, 2025 | Nov 18, 2025 | Springstubb Brendan BDirector | PPurchaseClass A Common Stock | +10K | $3.82 | +$38.2K | 58.82K | +20.5% | SEC |
| Mar 10, 2025 | Mar 6, 2025 | Holder DianeDirector | PPurchaseClass A Common Stock | +2.74K | $9.33 | +$25.52K | 70.58K | +4.0% | SEC |
| Mar 10, 2025 | Mar 6, 2025 | McCarthy Daniel JosephPRESIDENT | PPurchaseClass A Common Stock | +11.04K | $9.01 | +$99.47K | 389K | +2.9% | SEC |
| Mar 10, 2025 | Mar 7, 2025 | Jelinek Richard MDirector | PPurchaseClass A Common Stock | +30K | $9.125 | +$273.75K | 15K | New position | SEC |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in EVH at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Linden Advisors LP | – | $107.09M | 0.55% | – | – |
| BlackRock, Inc. | 14,814,851 | $85.91M | 0.00% | +3,925,979+36.1% | Added |
| Context Capital Management, LLC | – | $66.92M | 1.35% | – | – |
| CADIAN CAPITAL MANAGEMENT, LP | 10,814,473 | $58.61M | 4.44% | 00.0% | Unchanged |
| PenderFund Capital Management Ltd. | – | $50.5M | 6.47% | – | – |